Applications of inorganic nanoparticles as therapeutic agents
暂无分享,去创建一个
[1] M. Epple,et al. Silver as antibacterial agent: ion, nanoparticle, and metal. , 2013, Angewandte Chemie.
[2] Pablo Del Pino,et al. Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. , 2013, Small.
[3] X. Fang,et al. Protective effect of C70-carboxyfullerene against oxidative-induced stress on postmitotic muscle cells. , 2013, ACS applied materials & interfaces.
[4] E. Wang,et al. Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle , 2013, Proceedings of the National Academy of Sciences.
[5] Bing Wang,et al. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. , 2013, Accounts of chemical research.
[6] W. Kreyling,et al. Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. , 2013, Accounts of chemical research.
[7] Tian Xia,et al. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. , 2013, Accounts of chemical research.
[8] Lang Tran,et al. The biologically effective dose in inhalation nanotoxicology. , 2013, Accounts of chemical research.
[9] Amit Kumar,et al. Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing. , 2013, Biomaterials.
[10] N. Hanagata,et al. Oxide-based inorganic/organic and nanoporous spherical particles: synthesis and functional properties , 2013, Science and technology of advanced materials.
[11] C. Barbante,et al. Active Silver Nanoparticles for Wound Healing , 2013, International journal of molecular sciences.
[12] Matthias Epple,et al. Silver as antibacterial agent: ion, nanoparticle, and metal. , 2013, Angewandte Chemie.
[13] Shailendra Giri,et al. Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer , 2013, PloS one.
[14] Sudipta Seal,et al. Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria. , 2012, Biomaterials.
[15] Dohoung Kim,et al. Ceria nanoparticles that can protect against ischemic stroke. , 2012, Angewandte Chemie.
[16] Soumen Das,et al. Harnessing nanoparticles to improve toxicity after head and neck radiation. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[17] Morteza Mahmoudi,et al. Antibacterial properties of nanoparticles. , 2012, Trends in biotechnology.
[18] Leaf Huang,et al. Recent advances in nonviral vectors for gene delivery. , 2012, Accounts of chemical research.
[19] P. Tran,et al. Nanomaterial-based treatments for medical device-associated infections. , 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.
[20] Rachel A. Kudgus,et al. Intrinsic Therapeutic Applications of Noble Metal Nanoparticles: Past, Present and Future , 2012 .
[21] Mahesh K. Gangishetty,et al. Studies on antibacterial activity of ZnO nanoparticles by ROS induced lipid peroxidation. , 2012, Colloids and surfaces. B, Biointerfaces.
[22] Z. Aziz,et al. A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. , 2012, Burns : journal of the International Society for Burn Injuries.
[23] Silvia Licoccia,et al. Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. , 2012, ACS nano.
[24] Taeghwan Hyeon,et al. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. , 2012, Chemical Society reviews.
[25] M. Ahamed,et al. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species , 2012, International journal of nanomedicine.
[26] Wei Wang,et al. Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[27] Zainab N. Khan,et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. , 2012, Cancer cell.
[28] Marc Schneider,et al. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[29] Kaushal Rege,et al. Inorganic nanoparticles for cancer imaging and therapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[30] Yu-feng Li,et al. Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. , 2011, Small.
[31] J. Chipman,et al. Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. , 2011, Journal of wound care.
[32] R. Duncan,et al. Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.
[33] Kinam Park,et al. Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[34] Kazunori Kataoka,et al. Supramolecular nanodevices: from design validation to theranostic nanomedicine. , 2011, Accounts of chemical research.
[35] Soumen Das,et al. PEGylated Inorganic Nanoparticles , 2011 .
[36] Jian Zhang,et al. Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.
[37] Erin Lavik,et al. The role of nanomaterials in translational medicine. , 2011, ACS nano.
[38] E. Traversa,et al. Pharmacological potential of cerium oxide nanoparticles. , 2011, Nanoscale.
[39] K. Jeyasubramanian,et al. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[40] S. Sahoo,et al. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.
[41] Jun Fang,et al. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.
[42] Suntharampillai Thevuthasan,et al. PEGylated inorganic nanoparticles. , 2011, Angewandte Chemie.
[43] Wendelin J Stark,et al. Nanoparticles in biological systems. , 2011, Angewandte Chemie.
[44] Peter L. Irwin,et al. Antibacterial Activity and Mechanism of Action of Zinc Oxide Nanoparticles against Campylobacter jejuni , 2011, Applied and Environmental Microbiology.
[45] P. Couvreur,et al. Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system. , 2011, Biomacromolecules.
[46] S. Seal,et al. Redox-active radical scavenging nanomaterials. , 2010, Chemical Society reviews.
[47] Molly M. Stevens,et al. Rare earth oxides as nanoadditives in 3-D nanocomposite scaffolds for bone regeneration , 2010 .
[48] P. Kupelian,et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[49] S. Gurunathan,et al. Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model , 2010, International journal of nanomedicine.
[50] Manuela Semmler-Behnke,et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.
[51] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[52] G. Sotiriou,et al. Antibacterial activity of nanosilver ions and particles. , 2010, Environmental science & technology.
[53] Silvia Licoccia,et al. Stem Cell Aligned Growth Induced by CeO2 Nanoparticles in PLGA Scaffolds with Improved Bioactivity for Regenerative Medicine , 2010 .
[54] S. Seal,et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. , 2010, Chemical communications.
[55] Katsumi Kobayashi,et al. Platinum nanoparticles: a promising material for future cancer therapy? , 2010, Nanotechnology.
[56] Jeffrey I. Zink,et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery , 2010, BiOS.
[57] C. Rodríguez-Padilla,et al. Mode of antiviral action of silver nanoparticles against HIV-1 , 2010, Journal of nanobiotechnology.
[58] Sudipta Seal,et al. Anti-inflammatory properties of cerium oxide nanoparticles. , 2009, Small.
[59] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[60] Chenjie Xu,et al. FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition. , 2009, Journal of the American Chemical Society.
[61] Wei Li,et al. Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. , 2009, ACS nano.
[62] Ramanathan Vaidyanathan,et al. Antiangiogenic properties of silver nanoparticles. , 2009, Biomaterials.
[63] B. Delley,et al. Stability and morphology of cerium oxide surfaces in an oxidizing environment: A first-principles investigation , 2009 .
[64] V. Torchilin,et al. ATP-loaded liposomes for treatment of myocardial ischemia. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[65] Sudipta Seal,et al. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[66] Chenjie Xu,et al. Dumbbell-like Au-Fe3O4 nanoparticles for target-specific platin delivery. , 2009, Journal of the American Chemical Society.
[67] Stefan Bräse,et al. Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. , 2009, Chemical research in toxicology.
[68] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[69] Taeghwan Hyeon,et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. , 2008, Angewandte Chemie.
[70] Wenbin Lin,et al. Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[71] Xing-Jie Liang,et al. Inhibition of Tumor Growth by Endohedral Metallofullerenol Nanoparticles Optimized as Reactive Oxygen Species Scavenger , 2008, Molecular Pharmacology.
[72] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[73] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.
[74] Wenbin Lin,et al. Nanoscale coordination polymers for platinum-based anticancer drug delivery. , 2008, Journal of the American Chemical Society.
[75] C. Robic,et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.
[76] J. Imlay. Cellular defenses against superoxide and hydrogen peroxide. , 2008, Annual review of biochemistry.
[77] Sudipta Seal,et al. The role of cerium redox state in the SOD mimetic activity of nanoceria. , 2008, Biomaterials.
[78] Monty Liong,et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.
[79] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[80] Yunqing Kang,et al. Toxicological effect of ZnO nanoparticles based on bacteria. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[81] K. Tsuchida,et al. Recent advances in inorganic nanoparticle-based drug delivery systems. , 2008, Mini reviews in medicinal chemistry.
[82] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[83] M. Hall,et al. Basis for design and development of platinum(IV) anticancer complexes. , 2007, Journal of medicinal chemistry.
[84] M. Atkinson,et al. Novel synthesis of cerium oxide nanoparticles for free radical scavenging. , 2007, Nanomedicine.
[85] Yulong Ding,et al. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids) , 2007 .
[86] M. Das,et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. , 2007, Biomaterials.
[87] S. Seal,et al. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. , 2007, Chemical communications.
[88] L. Rogers,et al. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. , 2007, Cardiovascular research.
[89] J. Song,et al. Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli , 2007, Applied and Environmental Microbiology.
[90] Claudio Campa,et al. Targeting VEGF-A to treat cancer and age-related macular degeneration. , 2007, Annual review of medicine.
[91] Bing Xu,et al. FePt@CoS(2) yolk-shell nanocrystals as a potent agent to kill HeLa cells. , 2007, Journal of the American Chemical Society.
[92] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[93] R. Langer,et al. Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.
[94] S. Seal,et al. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides , 2006, Nature nanotechnology.
[95] Alex M. Fichtenholtz,et al. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. , 2006, Small.
[96] S. Silver,et al. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds , 2006, Journal of Industrial Microbiology and Biotechnology.
[97] M. Benedetti,et al. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. , 2006, Nano letters.
[98] Robert N Grass,et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.
[99] Napoleone Ferrara,et al. Angiogenesis as a therapeutic target , 2005, Nature.
[100] P. Liljeroth,et al. Physicochemical evaluation of the hot-injection method, a synthesis route for monodisperse nanocrystals. , 2005, Small.
[101] H. Maeda,et al. The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century , 2005 .
[102] R. Tarnuzzer,et al. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. , 2005, Nano letters.
[103] Ling Zhou,et al. Electron Localization Determines Defect Formation on Ceria Substrates , 2005, Science.
[104] Ling Wang,et al. Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.
[105] Chad A Mirkin,et al. Nanostructures in biodiagnostics. , 2005, Chemical reviews.
[106] Fumin Wang,et al. Hydrothermal Synthesis of Highly Crystallized Lepidocrocite Nanosheets of TiO2 under Low Temperature , 2005 .
[107] S. Gambhir,et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.
[108] A. Shah,et al. Role of oxidative stress in cardiac remodelling after myocardial infarction. , 2004, Heart, lung & circulation.
[109] J. Guggenbichler,et al. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. , 2004, International journal of antimicrobial agents.
[110] L. Ho,et al. Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity , 2004, Neurochemistry International.
[111] P. Alivisatos. The use of nanocrystals in biological detection , 2004, Nature Biotechnology.
[112] J. Imlay,et al. Pathways of oxidative damage. , 2003, Annual review of microbiology.
[113] J. Sawai. Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. , 2003, Journal of microbiological methods.
[114] S. Moghimi,et al. Real‐time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage‐prone nanoparticles to stealth entities by poloxamine 908 , 2003, FEBS letters.
[115] K. Hwang,et al. Fullerene derivative attenuates ischemia-reperfusion-induced lung injury. , 2003, Life sciences.
[116] Sung-Wook Choi,et al. Surface Modification of Functional Nanoparticles for Controlled Drug Delivery , 2003 .
[117] H. Dvorak. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[118] W. Dröge. Free radicals in the physiological control of cell function. , 2002, Physiological reviews.
[119] J. Rieger,et al. Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. , 2001, Angewandte Chemie.
[120] Taeghwan Hyeon,et al. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. , 2001, Journal of the American Chemical Society.
[121] C. Niemeyer. REVIEW Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science , 2022 .
[122] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[123] H. Maeda. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.
[124] K. Davies,et al. Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.
[125] D. Sorescu,et al. NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.
[126] V. Torchilin,et al. Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[127] C. K. Shen,et al. C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. , 1999, Journal of medicinal chemistry.
[128] C. Giandomenico,et al. Current status of platinum-based antitumor drugs. , 1999, Chemical reviews.
[129] Tronc,et al. Size Tailoring of Magnetite Particles Formed by Aqueous Precipitation: An Example of Thermodynamic Stability of Nanometric Oxide Particles. , 1998, Journal of colloid and interface science.
[130] Shen,et al. Carboxyfullerenes as neuroprotective agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[131] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[132] V. Torchilin,et al. Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .
[133] G. Paravicini,et al. Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine. , 1995, Biochemistry.
[134] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[135] Jürgen-Hinrich Fuhrhop,et al. Micelles and microemulsions , 1994 .
[136] B. Beaudoin,et al. Homogeneous and heterogeneous nucleations in the polyol process for the preparation of micron and submicron size metal particles , 1989 .
[137] R. Massart,et al. Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .